How would you describe the mission of the RRFS if you were explaining it to a member of the public? The Resident and Research Fellow Section is the young section of the European Academy of Neurology. The major aim is… Continue Reading

EAN Scientific Committee Chair, Thomas Berger, gives early notice of the upcoming elections for Scientific Panel Management Groups and an update on recent scientific activities.

For September 2021, we have selected: Ramsden CE et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial

For September 2021, we have selected: ''Aschman A et al. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died'' and ''Suh J et al. Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19''

The application deadline for the 2022 EAN Research Fellowships is 31.08.2021

Prof. Elena Lebedeva, member of the EAN Task Force on Gender and Diversity Issues in Neurology, interviews Prof. David Dodick, Professor of Neurology, Director of the Headache and Concussion Programs at Mayo Clinic in Arizona.

The European Academy of Neurology Board and Education Committee are pleased to announce the addition of four new e-Learning Associate Editors to the e-Learning Editorial Board. Together with Editor-in-Chief, Prof. Barbara Tettenborn, and the eLearning sub-committee, they will shape the future of EAN e-Learning activities.

The EAN-Day in Greece took place on 2 June, 2021, organised under the auspices of the EAN, the Hellenic Neurological Society and Professor Nikolaos Grigoriadis, the Head of the Hellenic Neurological Society.

Alzheimer Europe supported a call made on 25 June by European health NGOs, asking the European Commission to restore operating grants in the EU4Health Programme in order to support core activities of European NGOs.

In this article the authors aimed to analyse the range and prevalence of neurological and psychiatric complications associated with paediatric SARS-CoV-2 infection in hospitalised children and adolescents.

This paper aims to evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation from March 2020 to December 2020, and to investigate the association of SARS-CoV2 and Bell's palsy.

Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology

In this article the authors reviewed the scientific literature on movement disorders associated with Covid-19 published in English, spanning from the initial descriptions of COVID-19.

The objective of this multicentre retrospective cohort study was to develop and validate models that predict mortality of patients diagnosed with COVID-19 admitted to the hospital.

The objective of this study was to estimate the frequency of headache in patients with confirmed COVID-19 and characterize the phenotype of headache attributed to COVID-19, comparing patients depending on sex and the need for hospitalisation.